Boron-containing inhibitors of synthetases

Stephen J. Baker, John W. Tomsho, Stephen Benkovic

Research output: Contribution to journalReview article

141 Citations (Scopus)

Abstract

The use of boron in small-molecule pharmaceuticals is increasing. Boron's ubiquitous occurrence in nature and the recent success of a boronic acid drug (Velcade®) in the clinic have alleviated many concerns over its use in pharmaceuticals. In addition, the unique physicochemical properties of boronic acids make them an attractive addition to the medicinal chemists toolbox. This tutorial review will discuss these properties and potential benefits for anyone interested in finding novel enzyme inhibitors. An exceptional class of boronic acids, the oxaboroles, will be highlighted and their properties and uses will be discussed in detail. Finally, the current paradigm for the reaction of boronic acids with enzyme nucleophiles will be summarized.

Original languageEnglish (US)
Pages (from-to)4279-4285
Number of pages7
JournalChemical Society Reviews
Volume40
Issue number8
DOIs
StatePublished - Aug 1 2011

Fingerprint

Boronic Acids
Boron
Ligases
Pharmaceutical Preparations
Nucleophiles
Enzyme Inhibitors
Molecules
Enzymes

All Science Journal Classification (ASJC) codes

  • Chemistry(all)

Cite this

Baker, S. J., Tomsho, J. W., & Benkovic, S. (2011). Boron-containing inhibitors of synthetases. Chemical Society Reviews, 40(8), 4279-4285. https://doi.org/10.1039/c0cs00131g
Baker, Stephen J. ; Tomsho, John W. ; Benkovic, Stephen. / Boron-containing inhibitors of synthetases. In: Chemical Society Reviews. 2011 ; Vol. 40, No. 8. pp. 4279-4285.
@article{f46b55e6fccb43488a4dcc60f8aa11f3,
title = "Boron-containing inhibitors of synthetases",
abstract = "The use of boron in small-molecule pharmaceuticals is increasing. Boron's ubiquitous occurrence in nature and the recent success of a boronic acid drug (Velcade{\circledR}) in the clinic have alleviated many concerns over its use in pharmaceuticals. In addition, the unique physicochemical properties of boronic acids make them an attractive addition to the medicinal chemists toolbox. This tutorial review will discuss these properties and potential benefits for anyone interested in finding novel enzyme inhibitors. An exceptional class of boronic acids, the oxaboroles, will be highlighted and their properties and uses will be discussed in detail. Finally, the current paradigm for the reaction of boronic acids with enzyme nucleophiles will be summarized.",
author = "Baker, {Stephen J.} and Tomsho, {John W.} and Stephen Benkovic",
year = "2011",
month = "8",
day = "1",
doi = "10.1039/c0cs00131g",
language = "English (US)",
volume = "40",
pages = "4279--4285",
journal = "Chemical Society Reviews",
issn = "0306-0012",
publisher = "Royal Society of Chemistry",
number = "8",

}

Baker, SJ, Tomsho, JW & Benkovic, S 2011, 'Boron-containing inhibitors of synthetases', Chemical Society Reviews, vol. 40, no. 8, pp. 4279-4285. https://doi.org/10.1039/c0cs00131g

Boron-containing inhibitors of synthetases. / Baker, Stephen J.; Tomsho, John W.; Benkovic, Stephen.

In: Chemical Society Reviews, Vol. 40, No. 8, 01.08.2011, p. 4279-4285.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Boron-containing inhibitors of synthetases

AU - Baker, Stephen J.

AU - Tomsho, John W.

AU - Benkovic, Stephen

PY - 2011/8/1

Y1 - 2011/8/1

N2 - The use of boron in small-molecule pharmaceuticals is increasing. Boron's ubiquitous occurrence in nature and the recent success of a boronic acid drug (Velcade®) in the clinic have alleviated many concerns over its use in pharmaceuticals. In addition, the unique physicochemical properties of boronic acids make them an attractive addition to the medicinal chemists toolbox. This tutorial review will discuss these properties and potential benefits for anyone interested in finding novel enzyme inhibitors. An exceptional class of boronic acids, the oxaboroles, will be highlighted and their properties and uses will be discussed in detail. Finally, the current paradigm for the reaction of boronic acids with enzyme nucleophiles will be summarized.

AB - The use of boron in small-molecule pharmaceuticals is increasing. Boron's ubiquitous occurrence in nature and the recent success of a boronic acid drug (Velcade®) in the clinic have alleviated many concerns over its use in pharmaceuticals. In addition, the unique physicochemical properties of boronic acids make them an attractive addition to the medicinal chemists toolbox. This tutorial review will discuss these properties and potential benefits for anyone interested in finding novel enzyme inhibitors. An exceptional class of boronic acids, the oxaboroles, will be highlighted and their properties and uses will be discussed in detail. Finally, the current paradigm for the reaction of boronic acids with enzyme nucleophiles will be summarized.

UR - http://www.scopus.com/inward/record.url?scp=79958711382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958711382&partnerID=8YFLogxK

U2 - 10.1039/c0cs00131g

DO - 10.1039/c0cs00131g

M3 - Review article

C2 - 21298158

AN - SCOPUS:79958711382

VL - 40

SP - 4279

EP - 4285

JO - Chemical Society Reviews

JF - Chemical Society Reviews

SN - 0306-0012

IS - 8

ER -